In addition, we analyzed the effect of SHP2 on the prognosis of GC by Kaplan–Meier plotter, survival analysis showed that GC patients who with higher SHP2 expression lever indicated a worse prognosis (Figure 1E). This evidence concerns the gene PTPN11 and gastric cancer.